# Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye

> **NCT06860659** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Department of Medical Services Ministry of Public Health of Thailand** · enrollment: 84 (estimated)

## Conditions studied

- Dry Eye Disease (DED)
- Tear Break-Up Time
- Tear Disorder
- Tear Film Insufficiency
- Tear Film Hyperosmolarity
- Dry Eye
- Hyaluronate
- Hyaluronic Acid
- Corneal Staining
- Quality of Life

## Interventions

- **DRUG:** 0.28% Sodium Hyaluronate , preservative free eye drops
- **DRUG:** 0.18% Sodium Hyaluronate , preservative free eye drops

## Key facts

- **NCT ID:** NCT06860659
- **Lead sponsor:** Department of Medical Services Ministry of Public Health of Thailand
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-09-01
- **Primary completion:** 2025-05-26
- **Final completion:** 2025-06-26
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06860659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06860659, "Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06860659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*